Pieris Pharmaceuticals, Inc. - stock earnings
PIRS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -10.8 million USD | 19.5 million USD |
| 2023Q2 | 4.0 million USD | 20.1 million USD |
| 2023Q1 | -12.3 million USD | 1.9 million USD |
| 2022Q4 | -8.1 million USD | 5.8 million USD |
| 2022Q3 | -8.5 million USD | 5.4 million USD |
| 2022Q2 | -9.4 million USD | 3.7 million USD |
| 2022Q1 | -2.7 million USD | 11.0 million USD |
| 2021Q4 | -9.2 million USD | 8.4 million USD |
| 2021Q3 | -16.5 million USD | 4.1 million USD |
| 2021Q2 | -15.5 million USD | 3.3 million USD |
| 2021Q1 | -4.2 million USD | 15.6 million USD |
| 2020Q4 | -14.4 million USD | 1.9 million USD |
| 2020Q3 | -14.3 million USD | 2.9 million USD |
| 2020Q2 | -5.0 million USD | 11.2 million USD |
| 2020Q1 | -3.6 million USD | 13.3 million USD |
| 2019Q4 | -771000 USD | 17.3 million USD |
| 2019Q3 | -2.6 million USD | 15.1 million USD |
| 2019Q2 | -11.8 million USD | 5.3 million USD |
| 2019Q1 | -10.3 million USD | 8.5 million USD |
| 2018Q4 | -11.7 million USD | 4.9 million USD |
| 2018Q3 | -6.2 million USD | 8.3 million USD |
| 2018Q2 | -203000 USD | 11.7 million USD |
| 2018Q1 | -8.7 million USD | 4.2 million USD |
| 2017Q4 | 7.5 million USD | 18.2 million USD |
| 2017Q3 | -7.1 million USD | 3.9 million USD |
| 2017Q2 | -10.1 million USD | 1.9 million USD |
| 2017Q1 | -8.0 million USD | 1.3 million USD |
| 2016Q4 | -6.6 million USD | 2.7 million USD |
| 2016Q3 | -6.2 million USD | 785000 USD |
| 2016Q2 | -5.9 million USD | 1.1 million USD |
| 2016Q1 | -4.2 million USD | 1.2 million USD |
| 2015Q4 | -2.9 million USD | 2.1 million USD |
| 2015Q3 | -3.9 million USD | 414610 USD |
| 2015Q2 | -3.5 million USD | -244 USD |
| 2015Q1 | -3.7 million USD | 379 USD |
| 2014Q4 | -6.8 million USD | 3.3 million USD |
| 2014Q3 | -13918 USD | 19000 USD |
| 2014Q2 | -6208 USD | 698000 USD |
| 2014Q1 | -2198 USD | 1.4 million USD |
| 2013Q4 | -2198 USD | 12.4 million USD |
| 2013Q3 | -5762 USD | ? USD |
PIRS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -28.1 million USD | 47.4 million USD |
| 2022 | -31.3 million USD | 25.9 million USD |
| 2021 | -43.4 million USD | 31.4 million USD |
| 2020 | -37.2 million USD | 29.3 million USD |
| 2019 | -23.8 million USD | 46.3 million USD |
| 2018 | -26.8 million USD | 29.1 million USD |
| 2017 | -17.6 million USD | 25.3 million USD |
| 2016 | -22.8 million USD | 5.8 million USD |
| 2015 | -14.1 million USD | 2.9 million USD |
| 2014 | -9.8 million USD | 5.4 million USD |
| 2013 | 66196 USD | 9.9 million USD |
| 2012 | -274 USD | ? USD |
PIRS
Price: $11.68
52 week price:
Earnings Per Share: -0.34 USD
P/E Ratio: -0.54
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 522800
Ebitda: -5.1 millionMarket Capitalization: 17.5 million